Chagas disease diagnostic applications: present knowledge and future steps

V Balouz, F Agüero, CA Buscaglia - Advances in parasitology, 2017 - Elsevier
Chagas disease, caused by the protozoan Trypanosoma cruzi, is a lifelong and debilitating
illness of major significance throughout Latin America and an emergent threat to global …

[HTML][HTML] Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control

AE Bivona, AS Alberti, N Cerny, SN Trinitario… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Chagas disease is currently endemic to 21 Latin-American countries and has also become a
global concern because of globalization and mass migration of chronically infected …

Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury

H Wang, Q Wang, C Yang, M Guo, X Cui, Z Jing… - Gut …, 2022 - Taylor & Francis
The intestinal flora plays an important role in the development of many human and animal
diseases. Microbiome association studies revealed the potential regulatory function of …

Axl receptor induces efferocytosis, dampens M1 macrophage responses and promotes heart pathology in Trypanosoma cruzi infection

TS Rigoni, NS Vellozo, K Guimarães-Pinto… - Communications …, 2022 - nature.com
Adaptive immunity controls Trypanosoma cruzi infection, but the protozoan parasite persists
and causes Chagas disease. T cells undergo apoptosis, and the efferocytosis of apoptotic …

A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy

IR Pereira, G Vilar-Pereira, V Marques… - PLoS …, 2015 - journals.plos.org
Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a prototypical
neglected tropical disease. Specific immunity promotes acute phase survival. Nevertheless …

Recent advances in the development of adenovirus-vectored vaccines for parasitic infections

C Koger-Pease, DJ Perera, M Ndao - Pharmaceuticals, 2023 - mdpi.com
Vaccines against parasites have lagged centuries behind those against viral and bacterial
infections, despite the devastating morbidity and widespread effects of parasitic diseases …

Impairment of T cell function in parasitic infections

V Rodrigues, A Cordeiro-da-Silva… - PLoS neglected …, 2014 - journals.plos.org
In mammals subverted as hosts by protozoan parasites, the latter and/or the agonists they
release are detected and processed by sensors displayed by many distinct immune cell …

Immunopathogenesis in Trypanosoma cruzi infection: a role for suppressed macrophages and apoptotic cells

NS Vellozo, TC Matos-Silva, MF Lopes - Frontiers in Immunology, 2023 - frontiersin.org
During Trypanosoma cruzi infection, macrophages phagocytose parasites and remove
apoptotic cells through efferocytosis. While macrophage 1 (M1) produces proinflammatory …

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection

A Sanchez Alberti, AE Bivona, N Cerny, K Schulze… - npj Vaccines, 2017 - nature.com
The parasite Trypanosoma cruzi is the causative agent of Chagas disease, a potentially life-
threatening infection that represents a major health problem in Latin America. Several …

Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation

S Dhital, JV Stokes, N Park, KS Seo, BLF Kaplan - Cellular immunology, 2017 - Elsevier
Many effects of the non-psychoactive cannabinoid, cannabidiol (CBD), have been described
in immune responses induced by strong immunological stimuli. It has also been shown that …